Home | Feedback | Contact Us | Site Map | Privacy Statement
Organogenesis Inc. Living Technology
 
 
We'd Like to Learn...

more about you to help
us improve our products
and services.

 
 
 

Management Team

Executive Team

Geoff MacKay Geoff MacKay: President and Chief Executive Officer

Geoff MacKay has served in his current leadership role since December 2003. Mr. MacKay provides Organogenesis with significant global, commercial experience spanning the pharmaceutical and biotechnology sectors. Mr. MacKay has held numerous leadership positions within Novartis AG in roles such
as Vice-President and Business Unit Head,
Transplantation and Immunology at Novartis Canada, Vice-President of Tissue-Engineering in Novartis USA, Head of Global Sales Immunology and Transplantation based in Basel, Switzerland, and prior to that as Sales and Marketing Manager of Novartis Biotech Europe. Mr. MacKay has been specifically involved in the emerging field of regenerative medicine for the last decade.
     
     
Gary S. Gillheeney, Sr.: Executive Vice President, Chief Operating Officer and Chief Financial Officer

Gary Gillheeney's career in Operations and Finance spans over 24 years. Prior to joining Organogenesis, Mr. Gillheeney held executive positions at Innovative Clinical Solutions, Ltd. as Chief Operating Officer, Chief Financial Officer, as well as Treasurer and Secretary. Prior to that at Providence Energy Corporation he held positions as Senior Vice President, Chief Financial Officer, Treasurer, and Assistant Secretary. Mr. Gillheeney has a B.S. in Accounting from American International College and an MBA from Bryant College.
Gary S. Gillheeney
     
     

Dario Eklund

Dario Eklund: Vice President Bio-surgery and Bio-aesthetics

Dario Eklund has more than 15 years of senior management experience in the pharmaceutical and biotech industry. He joined Organogenesis from Aventis where he was Country Manager for Switzerland. Under his leadership, Aventis became the fastest growing major pharmaceutical company in the Swiss market. Mr. Eklund has also held senior management positions at Novartis Pharma as Director of Operations in South-East Europe and Israel, Commercial Director Biotech and later Head of Marketing and Sales in Tissue Engineering for markets outside the United States.

Mr. Eklund is a Finnish and Austrian national and holds a B.Sc. in Economics and a M.Sc. in Business Administration from the Swedish School of Economics and Business Administration in Helsinki, Finland.

     
     

Stephen Farrell: Vice President Bio-active Wound Healing

Stephen Farrell has over 20 years of experience in the pharmaceutical and biotechnology industry. Prior to joining Organogenesis, Mr. Farrell worked for over 10 years at Aventis holding numerous leadership roles there. He was the General Manager of their global Hemophilia Business Unit which had $600 million in sales of biologic and recombinant products. His span of control also included marketing, medical, logistics, and finance. Mr. Farrell also gained European experience as Managing Director of Aventis-Behring for the Nordic Region. Prior to Aventis, Mr. Farrell worked for over 5 years at Bristol-Myers Squibb in a variety of marketing positions.

Mr. Farrell holds a BA in Chemistry from Wesleyan University and an MBA from Columbia University.

Stephen Farrell

     
     
Vincent Ronfard Vincent Ronfard: Vice President of Research

Vincent Ronfard has more than 18 years experience in the field of regenerative medicine. He started his career at the Blood Transfusion Center (Lille, France) where
he developed a fibrin substrate to transplant human keratinocytes. In the fall of 2006, he joined Organogenesis Inc. from L'Oreal (U.S.A. and Paris) where he served as Associate Vice President/Director
of Reconstructed Skin Worldwide. Dr. Ronfard also served as Director of Research at Modex Therapeutics, which was an early pioneer in the field of regenerative medicine.

He holds a PhD in Cell Biology from the University of Compiegne, France and a graduate degree of Engineering in Agriculture from the University of Lille.
     
     

Damien Bates: Vice President of Medical Affairs

Damien Bates is a practicing board certified plastic & reconstructive surgeon with over 12 years of clinical experience in both the US and Australia. Prior to joining Organogenesis, Dr. Bates held a position as Global Medical Director for Baxter BioSurgery in the areas of soft and hard tissue repair.

Dr. Bates has holds an MD from the University of Sydney and a PhD in developmental biology from the University of Melbourne.

Damien Bates
     
     

Phillip Nolan

Phillip Nolan: Vice President of Manufacturing Operations

Phillip Nolan's career in manufacturing spans over 25 years with diverse industry experience including biomedical, medical device, custom injection molding and electronic products manufacturing in both large and small companies. At Organogenesis, Mr. Nolan is responsible for manufacturing operations and processes for all products.

Prior to joining Organogenesis, Mr. Nolan held senior leadership positions including Johnson and Johnson Medical, Inc. as Director of Operations for the manufacturing, engineering and distribution of a high volume medical device product line. Mr. Nolan is experienced in implementing lean manufacturing processes resulting in sustained improvements in cumulative lead times, delivery, costs, quality systems, and in building high performance teams.

Mr. Nolan has a B.S. in Design Engineering from Bradley University and a PMD from the Harvard School of Business.

     
     

Santino Costanzo: Vice President of Sales, Bio-active Wound Healing

Santino Costanzo's career in sales spans over 21 years. Santino applies learnings from his broad exposure to diverse fields including Tissue Regeneration/Regenerative Medicine, Pharmaceuticals and Construction. At Organogenesis, Mr. Costanzo has built a nationwide sales team and is responsible for Sales and Sales activities for the bio-active wound healing division - including the flagship product, Apligraf®.

Prior to joining Organogenesis, Mr. Costanzo held leadership positions with Novartis Pharmaceuticals as National Director of Sales in Tissue Engineering and various Management responsibilities within the pharmaceutical Divisions. Mr. Costanzo has experience in all aspects of the Selling functions and has developed highly effective and motivated sales teams throughout his career.

Santino Costanzo
     
     

Patrick Bilbo

Patrick Bilbo: Vice President of Regulatory

Patrick Bilbo has over 19 years experience in the medical products industry, with a broad range of expertise in the commercialization of new products including responsibility for clinical research, regulatory affairs and product development.  Previously he held management and research positions at Cytyc Corporation, Biofield and Stryker Corporation.  Prior to his career in industry, Mr. Bilbo gained four years of research experience in the Cell Biology Department at Harvard Medical School.

Mr. Bilbo has an MBA degree from the Boston University Graduate School of Management, Masters degrees in Cell Biology and Technology Strategy/Policy from the Boston University Graduate School of Arts & Sciences, and a B.S. degree in Biology from Syracuse University.

     
     

Richard Shaw: Vice President of Finance

Richard has over 15 years experience in finance and administration within the biotechnology industry. Richard began his career at Coopers and Lybrand LLP where he worked with a number of public and privately held biotechnology related companies including taking three companies public. Richard has been the corporate controller at Courion Corporation and Biopure Corporation. Richard joined Organogenesis in 2002 and oversees the day to day activities of the finance department.

Richard is a certified public accountant in Massachusetts. He has a Bachelors of Science in accounting from Babson College and a Masters in Taxation from Bentley College’s McCullum Graduate School of Business.

Richard Shaw

     
     

Houda E. Samaha

Houda E. Samaha: Human Resources Director

Houda Samaha recently joined Organogenesis as Director of Human Resources in 2005. Before joining Organogenesis, she served as a consultant to the organization on strategy, leadership and management development and organization change issues. Houda is on the Board of InteriorTrade.com, a business to business vertical market portal for the contract interior and architectural design trades. In addition, she is adjunct faculty at Harvard Business School, a guest lecturer at both Lesley University School of Management and Simmons Graduate Management School. Formerly Vice President, Board member, and Business Team Leader for organizational change/transition programs at Synectics, Inc., her professional career has spanned the private, public and academic sectors. Ms. Samaha holds a Baccalaureate and Master's degree from Boston University in Psychology and Sociology.